As of 4:00pm ET
| -0.84 / -3.17%|
The 9 analysts offering 12-month price forecasts for AMAG Pharmaceuticals Inc have a median target of 50.00, with a high estimate of 80.00 and a low estimate of 32.00. The median estimate represents a +94.70% increase from the last price of 25.68.
The current consensus among 9 polled investment analysts is to Buy stock in AMAG Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.